ArQule, Inc

Permanently closed

Photos

1 Wall St Ste 603
Burlington, MA 01803
ArQule is a biotechnology company engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize broadly effective cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics. ArQule develops cancer therapies based on proprietary activated Checkpoint TherapySM (ACTSM) platform by applying a unique molecular biology approach that leverages automated chemistries and intelligent drug design. The company was founded in 1993 and is located in Woburn, Mass.
Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2025. All rights reserved.